These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22034498)

  • 1. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
    Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
    Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
    Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S
    Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha.
    Pearce ST; Liu H; Radhakrishnan I; Abdelrahim M; Safe S; Jordan VC
    Cancer Res; 2004 Apr; 64(8):2889-97. PubMed ID: 15087408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
    Fretland AJ; Safe S; Hankinson O
    Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.
    Jin UH; Lee SO; Pfent C; Safe S
    BMC Cancer; 2014 Jul; 14():498. PubMed ID: 25011475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
    Morrow D; Qin C; Smith R; Safe S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
    Wormke M; Castro-Rivera E; Chen I; Safe S
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Wang WL; Porter W; Burghardt R; Safe SH
    Carcinogenesis; 1997 May; 18(5):925-33. PubMed ID: 9163677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
    Döhr O; Vogel C; Abel J
    Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.
    Jin UH; Lee SO; Safe S
    J Pharmacol Exp Ther; 2012 Nov; 343(2):333-41. PubMed ID: 22879383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
    Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
    Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells.
    Liu S; Abdelrahim M; Khan S; Ariazi E; Jordan VC; Safe S
    Biol Chem; 2006 Sep; 387(9):1209-13. PubMed ID: 16972788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat.
    Astroff B; Safe S
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
    Harris M; Zacharewski T; Astroff B; Safe S
    Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.